Mitozantrone
RxNorm 7005
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 7005 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Mitozantrone.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Ingredient (IN):
Mitoxantrone
(Atom ID: 12251606)
Tall Man Lettering Synonym (TMSY):
MitoXANTRONE
(Atom ID: 12428379)
Designated preferred name (PT):
Mitoxantrone
(Atom ID: 226701)
Full form of descriptor (FN):
Mitoxantrone (substance)
(Atom ID: 226721)
Designated preferred name (PT):
Mitoxantrone-containing product
(Atom ID: 10807370)
Synonym (SY):
Mitozantrone
(Atom ID: 2065992)
Full form of descriptor (FN):
Product containing mitoxantrone (medicinal product)
(Atom ID: 9724924)
Patient Education
Mitoxantrone Injection
Mitoxantrone injection is used to adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including the following: relapsing-remitting forms (course of disease where symptoms flare up from time to time), or progressive relapsing (course of disease with occasional relapses), or secondary progressive forms (course of disease where relapses occur more often). Mitoxantrone injection is also used together with steroid medications to relieve pain in people with advanced prostate cancer who did not respond to other medications. Mitoxantrone injection is also used with other medications to treat certain types of leukemia. Mitoxantrone injection is in a class of medications called anthracenediones. Mitoxantrone treats MS by stopping certain cells of the immune system from reaching the brain and spinal cord and causing damage. Mitoxantrone treats cancer by stopping the growth and spread of cancer cells.
[Learn More]
Cancer Chemotherapy
Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.
You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.
Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).
NIH: National Cancer Institute
[Learn More]
* Please review the disclaimer below.
